Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call

Core Viewpoint - Zevra Therapeutics, Inc. will report its third quarter 2025 corporate and financial results on November 5, 2025, followed by a conference call at 4:30 p.m. ET [1] Company Overview - Zevra Therapeutics, Inc. is a commercial-stage company focused on developing therapies for rare diseases that have limited or no treatment options [3] - The company's mission is to provide life-changing therapeutics to individuals living with rare diseases through innovative, data-driven development and commercialization strategies [3] Upcoming Events - The third quarter 2025 results will be released via a news release after market close on November 5, 2025 [1] - An audio webcast of the conference call will be available on the "Events & Presentations" page of Zevra's Investor Relations website [2] - A replay of the webcast will be accessible for 90 days starting approximately at 5:30 p.m. ET on the same day [2]